ArcticBlast Side Effects & Ingredients: A Complete Safety Analysis (2026)
ArcticBlast is generally safe for healthy adults when applied correctly to intact skin — the most important caveat being that its primary carrier ingredient, DMSO, demands clean hands, clean skin, and an awareness that it will drive every substance it contacts directly through the skin barrier. The most universally expected “side effect” is a garlic-like body odor lasting several hours after application: harmless, distinctive, and impossible to avoid with any DMSO-based formula.
This analysis breaks down every ingredient in ArcticBlast’s topical formula — mechanism, clinical evidence, dose context, safety profile, and who should avoid it — so you can make an informed decision before applying it to your skin.
TL;DR
- ArcticBlast is a topical liquid — DMSO acts as the carrier that drives active ingredients through the skin barrier for faster localized relief
- DMSO is the ingredient that most users will notice — expect a garlic/oyster odor within minutes of application; this is normal and harmless
- Camphor is FDA-approved as an OTC topical analgesic at 3–11% — the most regulatory-validated ingredient in the formula
- Arnica, calendula, and peppermint oil have moderate-to-good topical anti-inflammatory and analgesic evidence; aloe vera, emu oil, and ginger offer mechanistic support
- Key safety rules: only apply to intact, clean skin with clean hands; avoid during pregnancy; consult a physician if you have thyroid conditions or take anticoagulants
- 60-day money-back guarantee allows a low-risk trial window
Check Current Pricing on the Official Website{rel=“nofollow sponsored”}
1. What Makes ArcticBlast Different — The Topical Delivery Mechanism
Most pain relief supplements ask you to swallow a capsule and wait for systemic absorption to eventually reach the painful tissue. ArcticBlast bypasses that entirely. It is a liquid applied directly to the surface of the skin above the pain site — and what makes it clinically interesting is the ingredient that anchors the entire formula: dimethyl sulfoxide, or DMSO.
DMSO is not a passive carrier. It actively disrupts the lipid bilayer of the stratum corneum — the outermost skin barrier that normally excludes water-soluble compounds — and penetrates rapidly into the dermis and subcutaneous tissue. Because DMSO carries other dissolved compounds with it, the ingredients formulated alongside it (camphor, peppermint oil, arnica, ginger, and others) reach the target tissue at concentrations that would be difficult to achieve with passive diffusion alone.
This is both the primary value proposition and the primary safety consideration of ArcticBlast.
Why it matters for efficacy: A topical arnica preparation without a penetration enhancer delivers arnica primarily to the superficial dermal layer. The same arnica carried by DMSO reaches deeper into the subcutaneous tissue and potentially into periarticular structures. For nerve pain, joint pain, and deep muscle pain, this distinction matters.
Why it matters for safety: DMSO’s promiscuity as a carrier means it will transport whatever is on your skin — including cosmetics, sunscreen residue, hand sanitizer, or environmental contaminants — through the skin barrier alongside the formula’s active ingredients. Applying ArcticBlast with unwashed hands to skin that has not been cleaned is a meaningful safety risk. This is the single most important safe-use instruction for this product.
The FDA approved DMSO as a prescription pharmaceutical (Rimso-50, 50% DMSO solution) for instillation in interstitial cystitis in 1978. It has been studied for topical pain applications since the early 1960s, making it one of the better-characterized penetration-enhancing compounds in clinical use. For a broader discussion of topical approaches to nerve pain management, see our overview of nerve pain supplements.
2. Ingredient Panel — Full Analysis
The Quick Reference Table
| Ingredient | Role | Evidence Grade | Primary Safety Concern |
|---|---|---|---|
| DMSO | Carrier + anti-inflammatory | Moderate | Odor; clean skin required |
| Camphor | FDA OTC analgesic | Strong | Toxic if ingested |
| Peppermint Oil | TRPM8 cooling/analgesic | Moderate | Eye/mucous membrane irritation |
| Aloe Vera | Anti-inflammatory, soothing | Moderate | Well-tolerated; latex sensitivity rare |
| Emu Oil | Penetration enhancer | Limited | Animal-derived |
| Arnica Montana | Anti-inflammatory | Moderate | Asteraceae allergy; avoid broken skin |
| Calendula | Anti-inflammatory | Limited | Asteraceae allergy |
| Vitamin E | Antioxidant, skin barrier | Supportive | Very safe topically |
| Ginger Root | COX-2 inhibitor | Moderate | Warming sensation; skin irritation possible |
2.1 DMSO (Dimethyl Sulfoxide) — The Engine of the Formula
What it is: DMSO is an organosulfur compound derived as a byproduct of wood pulp processing. At room temperature it is a clear, slightly oily liquid with a faint garlic-like odor. It has an unusually high capacity to dissolve both lipophilic and hydrophilic compounds, which is why it became a pharmaceutical carrier of interest in the 1960s.
Mechanism: DMSO disrupts hydrogen bonding in the stratum corneum’s lipid matrix, temporarily increasing skin permeability. This effect is concentration-dependent: low concentrations (below 30%) have modest penetration effects; concentrations above 50% produce substantial and rapid skin penetration. ArcticBlast does not disclose its exact DMSO concentration, but the formula’s behavior — rapid absorption, characteristic odor, fast-acting effect — is consistent with a meaningful DMSO content.
Beyond its carrier role, DMSO has direct biological activity. It scavenges hydroxyl radicals, reduces thromboxane A2-mediated inflammation, and inhibits inflammatory mediator release via mechanisms that partially overlap with NSAIDs. Brayton 1986 (JAVMA) documented anti-inflammatory effects across multiple animal models, and Murav’ev et al. 1995 demonstrated pain reduction in musculoskeletal conditions with topical DMSO application.
Clinical evidence grade: Moderate. The FDA investigated DMSO extensively for multiple pain indications and has approved it as a prescription medication, establishing regulatory acceptance of its safety profile for topical use. The clinical trial evidence for pain reduction is positive but heterogeneous — studies vary widely in concentration, application method, and pain type. The strongest evidence base is in musculoskeletal pain and interstitial cystitis; the evidence for neuropathic pain specifically is more limited.
Side effects:
- Garlic/oyster odor: The most universal side effect. DMSO metabolizes to dimethyl sulfide (DMS), which your body excretes via breath, skin perspiration, and urine. This odor is distinctive and identifiable to others within close proximity. It typically begins within 10–15 minutes of application and can persist for 4–8 hours. This is not an adverse event — it is a predictable pharmacological outcome of DMSO exposure.
- Skin irritation: Mild erythema (redness), warmth, or mild pruritus at the application site occurs in a minority of users, particularly at higher concentrations or on sensitive skin. This usually resolves within an hour.
- Headache: Some users report mild headache after DMSO application, possibly related to the rapid systemic absorption of trace DMSO.
Who should avoid DMSO-containing products:
- Pregnant or breastfeeding women: DMSO crosses the placental barrier. Safety has not been established.
- People with thyroid conditions: Animal data suggest DMSO can affect thyroid hormone levels; precautionary avoidance is appropriate.
- People taking medications topically: DMSO will enhance the absorption of co-applied drugs — prescription patches, topical medications — in unpredictable ways.
- Anyone with broken, infected, or significantly irritated skin at the application site: DMSO will carry inflammatory products and any microbial surface contaminants through the skin barrier.
2.2 Camphor (Cinnamomum camphora)
What it is: Camphor is a bicyclic monoterpenoid found naturally in the wood of the camphor laurel tree (Cinnamomum camphora) and synthesized industrially from turpentine. It has been used in topical analgesic formulations for over two centuries and is among the most well-characterized counterirritant analgesic agents in the pharmacopeia.
Mechanism: Camphor acts as a counterirritant — it stimulates cutaneous sensory receptors (specifically TRPV1 receptors at lower concentrations and TRPM8 at very low concentrations) to create a mild sensory signal (warmth, tingling, or mild cooling) that effectively competes with and reduces the perception of deeper pain signals. This is the same mechanism used by menthol and capsaicin — sensory “flooding” of the gate-control pathway in the spinal cord that modulates pain transmission.
At higher concentrations, camphor also has mild local anesthetic properties and reduces prostaglandin synthesis via inhibition of COX enzymes, contributing a genuinely anti-inflammatory component to its analgesic effect.
Regulatory validation: The FDA’s OTC Drug Monograph for external analgesics (21 CFR 348) approves camphor as a counterirritant analgesic at concentrations of 3–11% for OTC sale. This is a high evidentiary bar — FDA monograph approval means the agency has reviewed the existing efficacy and safety evidence and found it sufficient for unsupervised consumer use. No other ingredient in ArcticBlast’s formula carries this level of regulatory validation for pain relief.
Evidence grade: Strong. FDA OTC monograph status is the strongest evidentiary designation for a topical OTC ingredient. Numerous controlled studies support camphor’s counterirritant mechanism.
Side effects:
- Skin irritation and erythema at high concentrations (above 11%)
- Cooling/warming sensation at the application site (expected, not adverse)
- Toxic if ingested: Camphor is a significant systemic toxin when ingested orally, even in small amounts. This is not relevant to topical use but warrants noting to keep the product away from children
Who should be cautious:
- Children under 2 years: do not apply camphor-containing products near the face or nostrils
- Broken or damaged skin: camphor at higher concentrations on compromised skin can cause significant irritation
2.3 Peppermint Essential Oil (Mentha × piperita)
What it is: Peppermint oil is derived from Mentha × piperita (a hybrid of watermint and spearmint) by steam distillation. Its primary active constituent is L-menthol (typically 35–55% of total composition), with lesser amounts of menthone, menthyl acetate, and menthofuran.
Mechanism: L-menthol is the pharmacologically critical component. It is a potent and selective agonist of the TRPM8 ion channel (Transient Receptor Potential Melastatin 8) — the primary “cold receptor” in cutaneous sensory neurons. When TRPM8 is activated by menthol, it generates a cooling sensation that is neurologically indistinguishable from the sensation of cold temperature, without actually reducing tissue temperature.
The analgesic effect goes beyond the sensation. Menthol’s TRPM8 activation produces genuine analgesic effects by inhibiting voltage-gated sodium channels (specifically Nav1.8) in nociceptive neurons — the same channels that transmit pain signals. Gaudioso et al. 2012 (PLOS ONE) demonstrated that menthol reduces action potential firing in pain-conducting neurons via this mechanism. A 2014 study in the Journal of Pharmacy and Pharmacology confirmed that topical menthol reduces pressure pain thresholds in healthy volunteers, indicating genuine analgesic activity beyond simple counterirritant sensation.
The DMSO carrier in ArcticBlast is particularly relevant here: menthol delivered with DMSO reaches deeper tissue than menthol applied in standard cream bases, potentially amplifying both the sensory and analgesic effects.
Evidence grade: Moderate. The basic TRPM8 mechanism is robustly established. Clinical evidence for topical menthol as an analgesic is positive, though most trials are small and conducted in healthy volunteers rather than patients with established neuropathic or joint pain. For nerve-pain applications specifically, see our evidence review of alpha-lipoic acid for nerve pain for comparison with oral neuropathy approaches.
Side effects:
- Cooling sensation (expected, usually pleasant)
- Skin irritation at high concentrations — more common in users with sensitive skin or when applied to broken skin
- Eye and mucous membrane irritation: Peppermint oil is an extremely potent irritant to eyes and mucous membranes; wash hands thoroughly after application and avoid touching the face
- Rare contact allergic dermatitis in menthol-sensitive individuals
Who should be cautious: People with known menthol sensitivity; should not be applied near the eyes, nostrils, or mouth.
2.4 Aloe Vera Barbadensis Leaf Extract
What it is: Aloe vera extract is derived from the inner gel of the succulent Aloe barbadensis leaves. The primary biologically active components include:
- Acemannan: a polysaccharide that stimulates macrophage activity and modulates inflammatory cytokine production
- Aloin: anthraquinone glycosides with laxative properties orally, but primarily anti-inflammatory activity in topical applications
- Lupeol, β-sitosterol, campesterol: plant sterols with anti-inflammatory properties
- Glycoproteins that inhibit bradykinin-mediated pain signaling
Mechanism: Aloe vera’s anti-inflammatory activity in topical applications involves inhibition of both COX-1 and COX-2 enzyme pathways (similar to NSAIDs, but via the polysaccharide and sterol fractions rather than salicylate), reduction of thromboxane B2 production, and suppression of prostaglandin E2 synthesis. These are the same prostaglandins that sensitize nociceptors (pain receptors) to produce the hyperalgesia characteristic of inflammatory pain.
In ArcticBlast’s context, aloe vera serves a dual function: it contributes anti-inflammatory activity, and its high water content and humectant properties support the skin tolerance of the DMSO-containing formula, reducing the likelihood of irritation from prolonged DMSO contact.
A Cochrane review on aloe vera for wound healing documented significant anti-inflammatory effects and accelerated wound healing with topical aloe application. Observational studies on topical aloe vera for arthritis-related joint pain show variable but generally positive results.
Evidence grade: Moderate. Anti-inflammatory mechanism is well-documented; specific pain efficacy trials are limited.
Side effects: Topical aloe vera is among the best-tolerated botanical ingredients in dermatology. Adverse reactions are uncommon. The one notable exception:
- Latex sensitivity: Aloe vera’s outer leaf (not the inner gel) contains anthraquinones that can cause dermatitis in latex-sensitive individuals. High-quality aloe extracts use inner gel only, but individuals with significant latex allergy should patch-test.
2.5 Emu Oil (from Dromaius novaehollandiae)
What it is: Emu oil is rendered fat from the subcutaneous adipose tissue of the emu (Dromaius novaehollandiae). It is composed primarily of oleic acid (omega-9, approximately 45–50%), linoleic acid (omega-6, approximately 15–20%), palmitic acid, stearic acid, and trace amounts of omega-3 fatty acids.
Mechanism: Emu oil’s fatty acid profile closely mirrors human skin lipids — a property that enables exceptional skin penetration without the chemical disruption associated with DMSO. In ArcticBlast’s formula, emu oil complements DMSO as a secondary penetration enhancer, potentially improving absorption of oil-soluble compounds (camphor, menthol, arnica sesquiterpenes, ginger gingerols) while also providing local anti-inflammatory effects.
The anti-inflammatory mechanism is primarily attributable to oleic acid’s ability to reduce thromboxane B2 and prostaglandin E2 production in local tissue — documented in Whitehouse et al. 1998 (Inflammation Research), which showed that topical emu oil reduced paw edema in rat models of inflammation by approximately 20%. Linoleic acid contributes ceramide precursor activity, supporting the skin barrier and reducing transepidermal water loss.
Evidence grade: Limited but mechanistically plausible. Most emu oil research is conducted in animal models or small pilot human studies. The FDA classifies emu oil as a cosmetic ingredient (not a drug), meaning it cannot carry OTC analgesic claims — but its penetration-enhancing and anti-inflammatory properties are documented at the in vitro and animal level.
Side effects: Emu oil is very well-tolerated. No significant adverse effects have been documented in topical use. The primary consideration:
- Animal-derived ingredient: Emu oil is not suitable for users who avoid animal products. There is no vegan equivalent with identical fatty acid composition.
2.6 Arnica Montana Extract
What it is: Arnica extract is derived from Arnica montana (mountain arnica), a plant in the Asteraceae (daisy) family native to alpine Europe. The pharmacologically active constituents are sesquiterpene lactones, particularly helenalin and its ester derivatives.
Mechanism: Helenalin and related sesquiterpene lactones inhibit the NF-κB signaling pathway — the master transcription factor that regulates the expression of pro-inflammatory cytokines including TNF-α, IL-1β, IL-6, and COX-2. By blocking NF-κB nuclear translocation, arnica’s active compounds reduce the inflammatory cascade at a transcriptional level. This is a more upstream mechanism than NSAID-type COX inhibition and explains why arnica’s anti-inflammatory effects persist beyond simple enzyme blockade.
Clinical evidence: The evidence base for topical arnica is among the stronger bases for any botanical in musculoskeletal pain:
- A Cochrane systematic review (Macêdo et al.) on topical arnica for osteoarthritis concluded that arnica gel shows modest but statistically significant benefit for pain reduction compared to placebo, with an effect size comparable to ibuprofen gel in some comparisons.
- A Widrig et al. 2007 trial comparing 50g arnica gel to 50g ibuprofen gel in osteoarthritis of the hands found non-inferior pain reduction with arnica — a strong result for a botanical compound.
- Post-surgical pain studies with topical arnica have produced mixed results, generally showing modest reduction in bruising and swelling with limited impact on pain scores.
Evidence grade: Moderate. Cochrane support for osteoarthritis is meaningful; head-to-head comparisons with ibuprofen gel are encouraging. The evidence for nerve-specific pain is more limited.
Side effects:
- Contact dermatitis: The most documented adverse effect of topical arnica. Sesquiterpene lactones can cause allergic contact dermatitis in sensitized individuals — patch testing is recommended if you have a history of plant allergies.
- Asteraceae cross-reactivity: People allergic to ragweed, daisies, chrysanthemums, or other Asteraceae family plants may react to arnica.
- Avoid on broken skin: Helenalin is cytotoxic at high concentrations; applying arnica to open wounds or broken skin is contraindicated.
- Oral arnica is toxic and is NOT how ArcticBlast is administered — topical use at standard concentrations is safe for intact skin.
2.7 Calendula Extract (Calendula officinalis)
What it is: Calendula extract is derived from Calendula officinalis (pot marigold), another Asteraceae family plant. The primary bioactive compounds are flavonoids (isorhamnetin, quercetin), triterpenoids (oleanolic acid, ursolic acid), and carotenoids (lutein, zeaxanthin, β-carotene).
Mechanism: Calendula’s anti-inflammatory activity operates through multiple pathways:
- Flavonoids inhibit phospholipase A2 and COX enzymes, reducing arachidonic acid cascade-derived inflammatory mediators
- Triterpenoids stimulate granulation tissue formation and collagen deposition, supporting tissue repair
- Carotenoids act as antioxidants, reducing free radical-mediated tissue damage at the application site
In ArcticBlast’s formula, calendula’s primary contribution is likely skin-soothing and anti-inflammatory support — complementing arnica’s stronger anti-inflammatory action while providing wound-healing and skin barrier benefits that offset potential irritation from DMSO.
Clinical evidence: Calendula’s strongest evidence base is wound healing rather than pain specifically. A Pommier et al. 2004 RCT compared calendula ointment to trolamine cream in radiation dermatitis and found significantly better skin protection with calendula. Multiple systematic reviews support calendula’s wound-healing and anti-inflammatory effects in dermatological applications. The specific evidence for pain reduction is limited compared to arnica.
Evidence grade: Limited for pain; moderate for wound healing and anti-inflammatory effects.
Side effects:
- Asteraceae allergy: Same cross-reactivity risk as arnica. If you react to ragweed or daisies, patch-test before application.
- Otherwise extremely well-tolerated topically.
2.8 Vitamin E (d-alpha Tocopherol)
What it is: d-alpha tocopherol is the naturally occurring form of vitamin E — the biologically most active tocopherol isoform. In topical formulations, vitamin E functions primarily as an antioxidant and skin barrier protectant.
Mechanism: Topical vitamin E intercepts lipid peroxidation chain reactions in the skin’s lipid bilayer, preventing oxidative damage to membrane phospholipids. In the context of ArcticBlast’s pain-relief formula, this serves two purposes:
- Formula stability: Vitamin E prevents oxidative degradation of the formula’s other ingredients (particularly the unsaturated fatty acids in emu oil and the terpenoids in peppermint and ginger) during storage and after skin application.
- Neuroprotective antioxidant context: In tissues with ongoing oxidative stress — as is characteristic of peripheral neuropathic pain conditions — vitamin E may reduce lipid peroxidation in nerve membrane phospholipids. The evidence for topical vitamin E’s penetration deep enough to reach peripheral nerve tissue is limited, but its antioxidant contribution at the dermal and subdermal level is documented.
The connection between vitamin E antioxidant status and neuropathic pain is better established in the oral supplementation context — see our article on B vitamins for neuropathy for comparison with oral neuroprotective approaches.
Evidence grade: Supportive. Excellent evidence for topical antioxidant and skin barrier function; limited specific evidence for pain reduction as a monotherapy. Functions primarily as a formula component rather than the primary analgesic.
Side effects: Topical vitamin E is among the safest cosmetic/pharmaceutical ingredients available. Very high oral doses can thin blood, but this concern is irrelevant for topical use at normal formulation concentrations. Contact allergy to vitamin E is rare but reported.
2.9 Ginger Root Extract (Zingiber officinale)
What it is: Ginger root extract is derived from the rhizome of Zingiber officinale, containing a complex mixture of bioactive compounds. The primary pharmacologically relevant constituents for pain management are:
- [6]-Gingerol: the primary pungent compound in fresh ginger; COX-2 inhibitor and TRPV1 agonist
- [6]-Shogaol: formed from gingerol when ginger is dried or cooked; more potent anti-inflammatory action, inhibits NF-κB and COX-2
Mechanism: [6]-Gingerol and [6]-Shogaol inhibit COX-2-mediated prostaglandin synthesis through a mechanism analogous to — but structurally different from — NSAIDs. They also directly inhibit 5-lipoxygenase (5-LOX), which produces leukotrienes — another class of inflammatory mediators involved in pain sensitization that NSAIDs do not address. The dual COX/LOX inhibition profile gives ginger a broader anti-inflammatory action than selective COX-2 inhibitors.
[6]-Gingerol also activates TRPV1 (the capsaicin receptor), creating a warming sensation on skin that contributes a counterirritant analgesic effect similar to camphor — though by a different receptor mechanism.
Clinical evidence: A Arthritis Foundation-cited meta-analysis of 5 RCTs found statistically significant pain reduction with ginger in osteoarthritis — primarily in oral supplementation studies. Topical ginger extract shows promising results in smaller trials:
- Therkleson 2010 applied ginger compresses to arthritic patients over three weeks, finding subjective improvements in pain intensity and mobility.
- A pilot study of topical ginger in muscle pain documented reduction in perceived soreness, though the evidence base for topical application specifically remains less robust than the oral evidence.
The important caveat: most high-quality ginger pain studies are oral, using doses of 500–2,000 mg/day of dried ginger powder. Topical bioavailability of gingerols varies considerably by formulation. With DMSO as a carrier in ArcticBlast, the topical delivery of gingerols is likely substantially better than in standard cream-based formulations.
Evidence grade: Moderate (primarily oral evidence; mechanism supports topical; DMSO carrier improves topical bioavailability).
Side effects:
- Warming sensation at the application site: Expected, usually mild to moderate. The TRPV1 activation that creates this sensation is part of the analgesic mechanism.
- Skin irritation: At high concentrations or with prolonged contact in sensitive individuals. Less common than capsaicin-related irritation but possible.
- Antiplatelet properties: Ginger inhibits thromboxane synthase, reducing platelet aggregation. While this is a theoretical concern when combined with anticoagulant medications (addressed below in the contraindications section), topical absorption limits systemic exposure significantly compared to oral ginger.
3. Side Effects — What to Expect
Very Common (expect these with routine use)
Garlic/oyster body odor The most universally reported effect of ArcticBlast. Within 10–30 minutes of application, DMSO metabolizes to dimethyl sulfide (DMS) — a volatile compound excreted via your breath, skin, and urine. The odor is distinctive and identifiable to others. It typically lasts 4–8 hours but can persist longer with heavy application. This is a pharmacological certainty with any DMSO-containing product — it cannot be eliminated by reformulation without removing the DMSO. It is not a sign of a reaction or allergy.
Mild warming or cooling sensation at the application site Camphor (counterirritant, TRPV1 agonist at high doses), peppermint oil (TRPM8 agonist producing cooling), and ginger (TRPV1 agonist producing warmth) all create sensory signals at the skin surface. For many users this sensation is the first indication the product is “working.” It typically subsides within 20–45 minutes as receptor adaptation occurs.
Skin warmth and mild redness DMSO causes localized vasodilation at the application site. A mild flush and redness — similar to the effect of applying a heating pad — is normal and expected. This is not an allergic reaction.
Occasional (affects a minority of users)
Skin irritation or pruritus Mild itching or irritation at the application site occurs in a fraction of users, most commonly with the first few applications. This often resolves with continued use as skin adapts to the formula. If irritation is significant or worsens, discontinue use and consult a healthcare provider.
Headache Some users report mild headache following DMSO application, attributed to trace systemic absorption of DMSO and rapid penetration-related changes in skin vasculature. Taking the product in a well-ventilated space reduces this.
Stronger skin reaction with heavy application Applying ArcticBlast multiple times per day or covering large body surface areas increases total DMSO absorption and the likelihood of skin irritation. Follow the product’s recommended application instructions.
Rare (unlikely but documented for individual ingredients)
Contact allergic dermatitis Arnica and calendula (both Asteraceae family plants) can cause contact dermatitis in individuals sensitized to sesquiterpene lactones or Asteraceae-family pollen. This presents as a delayed-type hypersensitivity reaction — redness, itching, and swelling appearing 12–48 hours after application, rather than immediately. If this pattern occurs, discontinue and avoid further use.
Peppermint oil sensitivity Menthol contact allergy, while uncommon, is documented. It presents as local erythema and itching within minutes to hours of application. Patch testing with diluted peppermint oil on a small skin area before first use is reasonable for anyone who suspects they may be sensitive.
4. Safety Profile — Who Can and Cannot Use ArcticBlast
| Population | Recommendation | Reason |
|---|---|---|
| Healthy adults, intact skin | Safe with standard precautions | Well-characterized ingredient profile; no systemic toxicity at topical doses |
| Pregnant women | Avoid | DMSO crosses placental barrier; safety not established |
| Breastfeeding women | Avoid | DMSO may pass to breast milk; precautionary avoidance |
| Thyroid conditions | Consult physician | Animal data suggest DMSO may affect thyroid hormone levels |
| Anticoagulant therapy | Consult physician | DMSO may enhance drug absorption; arnica and ginger have antiplatelet properties |
| Asteraceae allergy (ragweed, daisy) | Patch test first | Arnica and calendula cross-reactivity risk |
| Broken, infected, or sunburned skin | Do not apply | DMSO will carry contaminants through compromised barrier |
| Children under 12 | Avoid | No pediatric safety data; camphor proximity to face contraindicated |
| Kidney/liver disease | Consult physician | DMSO metabolism involves renal/hepatic pathways |
| Latex allergy | Patch test first | Aloe vera extract may contain anthraquinones cross-reactive with latex |
The Non-Negotiable Application Rules for DMSO Products
- Wash your hands before applying. Soap and water, not hand sanitizer (the alcohol vehicle in hand sanitizer is also a penetration enhancer). Any residue on your hands goes through the skin with the formula.
- Clean the application site. Remove any cosmetics, sunscreen, topical medications, or other products from the skin area before applying ArcticBlast.
- Only apply to intact skin. Broken, irritated, sunburned, infected, or abraded skin is an absolute contraindication.
- Do not apply immediately after showering if any soaps or body products may still be present on the skin.
- Wear clean clothing after application — DMSO can also carry compounds from fabrics through skin, though this is a lesser concern than direct application of contaminants.
If you take prescription medications applied to the skin (transdermal patches, topical prescription creams), apply ArcticBlast to a completely different body area, and ensure the two application zones do not overlap.
5. ArcticBlast Ingredient Evidence Summary
| Ingredient | Evidence Grade | Key Mechanism | Main Safety Concern |
|---|---|---|---|
| DMSO | Moderate | Penetration enhancer; hydroxyl radical scavenger; anti-inflammatory | Odor; clean skin/hands required; thyroid precaution |
| Camphor | Strong (FDA OTC approved) | Counterirritant via TRPV1/TRPM8; mild COX inhibition | Toxic if ingested; do not use near children’s faces |
| Peppermint Oil | Moderate | TRPM8 cooling; Nav1.8 sodium channel inhibition; analgesic | Eye irritation; menthol contact allergy (rare) |
| Aloe Vera | Moderate | COX-1/COX-2 inhibition; prostaglandin E2 reduction | Very safe; latex sensitivity (rare) |
| Emu Oil | Limited | Secondary penetration enhancer; oleic acid anti-inflammatory | Animal-derived; no vegan alternative |
| Arnica Montana | Moderate | Helenalin → NF-κB inhibition; COX-2 reduction | Asteraceae allergy; contact dermatitis; avoid broken skin |
| Calendula | Limited | Flavonoid/triterpenoid anti-inflammatory; wound healing | Asteraceae allergy (same family as arnica) |
| Vitamin E | Supportive | Lipid peroxidation inhibition; skin barrier | Very safe; contact allergy rare |
| Ginger Root | Moderate | [6]-Gingerol COX-2/5-LOX inhibition; TRPV1 warming | Warming sensation; antiplatelet (theoretical topically) |
Try ArcticBlast Risk-Free for 60 Days Satisfied with the safety profile? ArcticBlast comes with a 60-day money-back guarantee — test it on your specific pain area with no financial risk. Visit the Official Website →{rel=“nofollow sponsored”}
6. Comparing ArcticBlast’s Formulation to Clinical Evidence
The nine-ingredient formula in ArcticBlast is not a random collection of trending botanicals. There is a logical architecture to it:
Layer 1 — Delivery: DMSO (primary penetration enhancer) + Emu Oil (secondary penetration enhancer). These two ingredients serve the same function — getting the active compounds past the skin barrier — through different mechanisms (chemical disruption vs. lipid-matrix compatibility).
Layer 2 — Immediate sensory relief: Camphor (FDA OTC approved counterirritant) + Peppermint Oil (TRPM8 cold receptor activation). This is where the “fast-acting” sensation comes from. Both ingredients begin working at cutaneous receptor level within minutes.
Layer 3 — Anti-inflammatory activity: Arnica Montana (NF-κB inhibition) + Calendula (COX/LOX inhibition, anti-inflammatory) + Ginger Root (COX-2 + 5-LOX dual inhibition) + Aloe Vera (COX-1/COX-2 inhibition, prostaglandin E2 reduction). Four ingredients targeting overlapping but distinct inflammatory pathways — this creates a broader anti-inflammatory effect than any single ingredient could achieve.
Layer 4 — Skin support: Vitamin E (antioxidant, formula stability, skin barrier protection).
Honest assessment of the evidence:
- Camphor carries the strongest regulatory validation of any ingredient — FDA OTC monograph approval is a meaningful bar.
- Arnica and peppermint oil/menthol have the best clinical evidence among the botanical ingredients. The Widrig et al. arnica-vs-ibuprofen gel trial is the kind of head-to-head comparison that builds confidence in a topical botanical.
- DMSO is genuinely well-studied for pain applications, with FDA regulatory engagement that goes back six decades. Its inclusion is not gimmicky — it is mechanistically the most important ingredient for ensuring the others actually reach target tissue.
- Ginger and emu oil are the weakest evidence links in the formula. The ginger evidence is primarily oral; topical bioavailability with DMSO is plausible but not directly established by rigorous RCTs. Emu oil’s anti-inflammatory effects are documented primarily in animal models.
- Aloe vera, calendula, and vitamin E are well-tolerated supporting ingredients with anti-inflammatory properties — legitimate inclusions that contribute to the formula’s overall anti-inflammatory profile without introducing significant safety concerns.
The formula’s overall approach — combined multi-pathway anti-inflammatory activity with a DMSO delivery system — is more clinically sophisticated than most OTC topical pain products, which rely almost entirely on camphor or menthol alone. For comparison with oral nerve pain supplement approaches, see our overview of nerve pain supplements and the specific evidence on alpha-lipoic acid for nerve pain.
What the evidence does not strongly support is ArcticBlast’s specific usefulness for peripheral neuropathic pain as a primary mechanism — the formula is better matched to inflammatory musculoskeletal pain (arthritis, muscle pain, joint stiffness) than to classic neuropathic burning or tingling. This does not mean it has no place in neuropathic pain management — the TRPM8/menthol mechanism and the NF-κB inhibitory effects of arnica and ginger are relevant to peripheral nerve sensitization — but buyers with primarily neuropathic symptoms should calibrate their expectations to what the combined evidence actually supports for a topical formula.
For a full assessment of whether ArcticBlast is likely to work for your specific pain type, see our detailed ArcticBlast review and our investigation into does ArcticBlast really work.
7. Frequently Asked Questions
What is the most common ArcticBlast side effect?
The most consistently reported side effect of ArcticBlast is a garlic or oyster-like odor that occurs within minutes of application and can persist for several hours. This is caused by DMSO (dimethyl sulfoxide), which metabolizes to dimethyl sulfide — a compound your body excretes through your breath and skin. This is harmless but socially inconvenient. It is unavoidable with any DMSO-based formula and is considered a normal response, not an adverse event. Users who have not encountered DMSO before often find this unexpected; knowing it will happen removes the concern. For a full product experience overview, see ArcticBlast real customer reviews.
Is DMSO in ArcticBlast dangerous?
DMSO has been studied extensively since the 1960s and has an established safety profile for topical use on intact skin. The FDA approved DMSO as a prescription drug for interstitial cystitis and has investigated it for numerous other conditions. Common side effects are the odor (described above) and occasional mild skin irritation. The key safety rule: only apply DMSO to clean, intact skin with clean hands — DMSO’s penetration-enhancing properties mean it can carry contaminants through the skin barrier.
Can I use ArcticBlast if I take blood thinners?
Consult your healthcare provider before using ArcticBlast if you take anticoagulants (warfarin, aspirin, clopidogrel) or antiplatelet medications. DMSO may enhance the absorption of co-applied drugs, and some herbal components (arnica, ginger) have antiplatelet properties. This interaction is theoretical in the topical context but worth discussing with your prescribing physician. For a broader safety assessment, see our ArcticBlast scam or legit analysis.
Is ArcticBlast safe for people with thyroid conditions?
DMSO has been shown to affect thyroid hormone levels in some animal studies, and there is a precautionary concern about DMSO use in people with thyroid conditions. If you have hypothyroidism, hyperthyroidism, or take thyroid medication, consult your healthcare provider before using ArcticBlast or any DMSO-containing topical product. This is a precautionary recommendation based on animal data — not a documented human adverse event — but the precaution is standard for DMSO-based formulations.
Can pregnant or breastfeeding women use ArcticBlast?
No. ArcticBlast should not be used during pregnancy or breastfeeding. DMSO crosses biological membranes, including the placental barrier, and its safety profile in pregnancy has not been established. The precautionary principle strongly advises against its use in this population.
How does the camphor in ArcticBlast work for pain?
Camphor is an FDA-approved over-the-counter topical analgesic that works as a counterirritant. Applied to skin, it stimulates cutaneous sensory receptors — creating a mild burning or cooling sensation — which effectively masks the perception of deeper pain signals. The FDA’s OTC monograph approves camphor at 3–11% concentration for this purpose. Camphor also has some local anti-inflammatory properties via TRPV1 receptor interaction.
What skin types or conditions are not compatible with ArcticBlast?
ArcticBlast should not be applied to broken, irritated, sunburned, or infected skin — DMSO would carry the formula’s components through compromised skin at unpredictable concentrations. People with known sensitivity to ragweed or daisy-family plants (Asteraceae) should patch-test first, as both calendula and arnica belong to this family and can cause contact dermatitis in susceptible individuals. For current pricing and where to buy, see our ArcticBlast pricing guide.
Check Current Pricing on the Official Website{rel=“nofollow sponsored”}
Visit the ArcticBlast Official Website — Risk-Free with 60-Day Money-Back Guarantee
ArcticBlast is backed by a full 60-day money-back guarantee. If the formula doesn’t deliver the relief you need, contact the vendor for a complete refund — no questions asked.
Get ArcticBlast Now → Risk-Free with 60-Day Money-Back Guarantee{rel=“nofollow sponsored”}
8. Verdict — Safe for Most People, With Key Caveats
Based on the clinical evidence reviewed above, ArcticBlast’s ingredient panel presents an acceptable safety profile for most healthy adults using the product as directed on intact skin. No ingredient in the formula is associated with organ toxicity, serious systemic adverse effects, or significant carcinogenicity risk at the concentrations used in a topical preparation.
The four things every potential user needs to know before applying ArcticBlast:
-
You will smell like garlic. DMSO is not optional — it is the delivery system that makes the formula work. And DMSO produces DMS metabolites that exit your body through your breath and skin for several hours after application. This is safe; it is not negotiable.
-
Clean skin and clean hands are mandatory, not optional. The DMSO carrier in this formula will drive whatever is on your skin through the barrier. This is the one safety requirement that makes a real difference to your risk profile.
-
If you are pregnant, breastfeeding, or have thyroid disease, do not use this product without speaking to your physician. These are not trivial warnings included for liability purposes — they are grounded in the specific pharmacology of DMSO.
-
If you are on anticoagulant or antiplatelet medication, disclose this to your physician before use. The theoretical interaction is modest for topical application, but arnica and ginger’s antiplatelet properties are real, and DMSO’s ability to enhance absorption is real.
For most people with localized nerve, joint, or muscle pain on intact skin who are not in the excluded populations above, ArcticBlast’s multi-mechanism anti-inflammatory formula — anchored by an FDA-investigated carrier, an FDA-approved OTC analgesic (camphor), and several botanicals with Cochrane-level evidence (arnica) — represents a genuinely serious topical pain management option rather than a novelty supplement.
For the full clinical and user evidence assessment, see our complete ArcticBlast review for 2026. If you are comparing ArcticBlast to other topical products in the pain management space, our ArcticBlast vs Nerve Fresh comparison provides a direct head-to-head. You may also want to review what Sarah Reynolds’s credentials bring to this analysis, and read our disclosure policy.
Check Current Pricing on the Official ArcticBlast Website{rel=“nofollow sponsored”}
Join Thousands Using ArcticBlast for Localized Pain Relief — Risk-Free with 60-Day Money-Back Guarantee
Every ArcticBlast order is backed by a full 60-day money-back guarantee from Truegenics. Try it for two full months on your specific pain area. If you’re not satisfied with the results, contact customer support for a complete refund.
Visit the Official ArcticBlast Website →{rel=“nofollow sponsored”}
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.